Soluble Urokinase Receptor and Chronic Kidney Disease

BACKGROUND: Relatively high plasma levels of soluble urokinase-type plasminogen activator receptor (suPAR) have been associated with focal segmental glomerulosclerosis and poor clinical outcomes in patients with various conditions. It is unknown whether elevated suPAR levels in patients with normal...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:N Engl J Med
Auteurs principaux: Hayek, Salim S., Sever, Sanja, Ko, Yi-An, Trachtman, Howard, Awad, Mosaab, Wadhwani, Shikha, Altintas, Mehmet M., Wei, Changli, Hotton, Anna L., French, Audrey L., Sperling, Laurence S., Lerakis, Stamatios, Quyyumi, Arshed A., Reiser, Jochen
Format: Artigo
Langue:Inglês
Publié: 2015
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4701036/
https://ncbi.nlm.nih.gov/pubmed/26539835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1506362
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires